Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
Biomed Res Int. 2013;2013:686549. doi: 10.1155/2013/686549. Epub 2013 Jul 30.
The ectodomain of matrix protein 2 (M2e) is highly conserved among influenza A viruses and can be a promising candidate antigen for a broadly cross-protective vaccine. In this study, a tetrameric M2e (tM2e) and a truncated form of flagellin (tFliC) were coincorporated into virus-like particles (VLPs) to enhance its immunogenicity. Our data showed that the majority of M2e in VLPs was presented as tetramers by introducing a foreign tetramerization motif GCN4. Intranasal immunization with tM2e VLPs significantly enhanced the levels of serum IgG and IgG subclasses compared to soluble M2e (sM2e) in mice. tM2e VLPs also induced higher M2e-specific T-cell and mucosal antibody responses, conferring complete protection against homologous influenza virus infection. The immunogenicity of tM2e VLPs was further enhanced by coincorporation of the membrane-anchored tFliC (tM2e chimeric VLPs) or coadministration with tFliC VLPs as a mixture, but not the soluble flagellin, inducing strong humoral and cellular immune responses conferring cross-protection against lethal challenge with heterotypic influenza viruses. These results support the development of tM2e chimeric VLPs as universal vaccines and warrant further investigation.
基质蛋白 2(M2e)的外结构域在甲型流感病毒中高度保守,是一种有前途的广谱保护性疫苗候选抗原。在这项研究中,将四聚体 M2e(tM2e)和截短的鞭毛蛋白(tFliC)共包被到病毒样颗粒(VLPs)中以增强其免疫原性。我们的数据表明,通过引入外源四聚化基序 GCN4,VLPs 中的大多数 M2e 呈四聚体形式存在。与可溶性 M2e(sM2e)相比,鼻腔内免疫 tM2e VLPs 可显著提高小鼠血清 IgG 和 IgG 亚类的水平。tM2e VLPs 还诱导了更高的 M2e 特异性 T 细胞和黏膜抗体应答,对同源流感病毒感染提供完全保护。通过共包被膜锚定的 tFliC(tM2e 嵌合 VLPs)或与 tFliC VLPs 混合共给药(而不是可溶性鞭毛蛋白)可进一步增强 tM2e VLPs 的免疫原性,诱导强烈的体液和细胞免疫应答,对致死性异源流感病毒攻击提供交叉保护。这些结果支持开发 tM2e 嵌合 VLPs 作为通用疫苗,并值得进一步研究。